Data as of 3:59pm ET
| -0.20 / -1.30%|
The 6 analysts offering 12-month price forecasts for Celldex Therapeutics Inc have a median target of 15.50, with a high estimate of 20.00 and a low estimate of 14.00. The median estimate represents a +1.97% increase from the last price of 15.20.
The current consensus among 7 polled investment analysts is to Buy stock in Celldex Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.